-
cancer patients, we have delivered data-driven solutions for accurate prediction of prognosis and real-time outcome monitoring of surgical performance. Most recently, we have used existing data to train
-
of existing buildings to single room and digital signage upgrades. This can also include moves/re-use of existing equipment to make best use of assets and budgets available. As well as teaching and learning
-
Mark Cragg and Stephen Beers, alongside Dr Stephen Thirdborough, aim to leverage the significant antibody capabilities and expertise at Boehringer to develop new and more effective antibody reagents
-
challenges. As a world-leading, research-intensive university, with a strong and high-quality educational offering, we are renowned for our innovation and enterprise and are within the top 1% of universities
-
for the successful postholder to grow and develop. Who are we? The NIHR funds, enables, and delivers world-leading health and social care research that improves people's health and well-being and promotes economic